(Q34726004)

4 August 2017

1 reference

title

Tuning tumor-specific T-cell activation: a matter of costimulation? (English)

1 reference

4 August 2017

5

Barbara Seliger

1 reference

4 August 2017

Hinrich Abken

1

1 reference

4 August 2017

Andreas Hombach

series ordinal

2

1 reference

4 August 2017

Claudia Heuser

series ordinal

3

1 reference

4 August 2017

Kai Kronfeld

series ordinal

4

1 reference

4 August 2017

1 May 2002

1 reference

4 August 2017

1 reference

4 August 2017

23

1 reference

4 August 2017

5

1 reference

4 August 2017

240-245

1 reference

Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

CD4 help-independent induction of cytotoxic CD8 cells to allogeneic P815 tumor cells is absolutely dependent on costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Manipulation of costimulatory signals to enhance antitumor T-cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Enhancement of the anti-tumor immune response using a combination of interferon-gamma and B7 expression in an experimental mammary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

GM-CSF and B7-1 (CD80) co-stimulatory signals co-operate in the induction of effective anti-tumor immunity in syngeneic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Engineering and characterization of a novel fusion protein incorporating B7.2 and an anti-ErbB-2 single-chain antibody fragment for the activation of Jurkat T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Targeting of a B7-1 (CD80) immunoglobulin G fusion protein to acute myeloid leukemia blasts increases their costimulatory activity for autologous remission T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Help for cytotoxic-T-cell responses is mediated by CD40 signalling.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

The TRAIL to selective tumor death

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Engagement of the OX-40 receptor in vivo enhances antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

CD4+ T cells engrafted with a recombinant immunoreceptor efficiently lyse target cells in a MHC antigen- and Fas-independent fashion.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30(+) cutaneous lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

OX40: targeted immunotherapy--implications for tempering autoimmunity and enhancing vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

The LFA-1/ICAM cell adhesion pathway is involved in tumor-cell lysis mediated by bispecific monoclonal-antibody-targeted T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

T cell costimulation by the TNF ligand BAFF.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Endothelial cell costimulation of T cell activation through CD58-CD2 interactions involves lipid raft aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Involvement of the protein tyrosine kinase p56lck in T cell signaling and thymocyte development.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Influence of antigen dose and costimulation on the primary response of CD8+ T cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

CD28/B7 costimulation: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

1 reference

7 January 2021

Signaling through OX40 (CD134) breaks peripheral T-cell tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Melphalan and other anticancer modalities up-regulate B7-1 gene expression in tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Integrated src kinase and costimulatory activity enhances signal transduction through single-chain chimeric receptors in T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Functional expression of chimeric receptor genes in human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902180-4

7 January 2021

10.1016/S1471-4906(02)02180-4

Identifiers

DOI

1 reference

4 August 2017

1 reference